Medincell (France) Today
| MEDCL Stock | EUR 17.70 0.28 1.61% |
Performance0 of 100
| Odds Of DistressLess than 26
|
Medincell is selling at 17.70 as of the 25th of November 2024; that is 1.61% up since the beginning of the trading day. The stock's last reported lowest price was 17.24. Medincell has about a 26 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Medincell SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of October 2024 and ending today, the 25th of November 2024. Click here to learn more.
It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceutical ingredients. Its product candidates in formulation research comprise subcutaneous injections, such as mdc-WWM for contraception mdc-ANG for CNS related treatments mdc-ELK for depression and mdc-GRT for use in organ transplant, as well as perineural injections, including mdc-CMV for anesthesia and pain, and mdc-NVA for pain. The company has 25.22 M outstanding shares. More on Medincell SA
Moving against Medincell Stock
Medincell Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Medincell's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Medincell or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Medincell SA (MEDCL) is traded on Euronext Paris in France and employs 151 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 215.89 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medincell's market, we take the total number of its shares issued and multiply it by Medincell's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Medincell SA operates under Healthcare sector and is part of Biotechnology industry. The entity has 25.22 M outstanding shares.
Medincell SA has accumulated about 5 M in cash with (21.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.24.
Check Medincell Probability Of Bankruptcy
Ownership AllocationMedincell SA maintains a total of 25.22 Million outstanding shares. Medincell SA holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Medincell Ownership Details
Medincell SA Risk Profiles
Although Medincell's alpha and beta are two of the key measurements used to evaluate Medincell's performance over the market, the standard measures of volatility play an important role as well.
Medincell Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Medincell without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
| All Next | Launch Module |
Medincell Corporate Management
Elected by the shareholders, the Medincell's board of directors comprises two types of representatives: Medincell inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medincell. The board's role is to monitor Medincell's management team and ensure that shareholders' interests are well served. Medincell's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medincell's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joel Richard | Member Board | Profile | |
| Quiterie Beauregard | Head Portfolio | Profile | |
| Helen Martin | Head Management | Profile | |
| Julie Alimi | Head Legal | Profile | |
| Sebastien Enault | Chief Officer | Profile | |
| Christophe Douat | Chairman of the Management Board | Profile | |
| Jaime Arango | Financial and Administrative Director | Profile |
Additional Tools for Medincell Stock Analysis
When running Medincell's price analysis, check to measure Medincell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medincell is operating at the current time. Most of Medincell's value examination focuses on studying past and present price action to predict the probability of Medincell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medincell's price. Additionally, you may evaluate how the addition of Medincell to your portfolios can decrease your overall portfolio volatility.